These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26135132)

  • 21. Evidence and nuances of propranolol safety.
    Püttgen KB
    Br J Dermatol; 2015 Feb; 172(2):319-20. PubMed ID: 25660680
    [No Abstract]   [Full Text] [Related]  

  • 22. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
    Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
    Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reply of the authors.
    Horev A; Haim A; Zvulunov A
    Pediatr Endocrinol Rev; 2015 Sep; 13(1):479. PubMed ID: 26540766
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to "Propranolol Induced Hypoglycemia" by Amir Horev, MD, Alon Haim, MD, Alex Zvulunov, MD.
    Theiler M; Drolet BA; Frieden IJ
    Pediatr Endocrinol Rev; 2015 Sep; 13(1):477-8. PubMed ID: 26540765
    [No Abstract]   [Full Text] [Related]  

  • 25. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma.
    Greene AK
    Pediatr Dermatol; 2010; 27(3):322-3. PubMed ID: 20609168
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-blockers for infantile hemangiomas: a single-institution experience.
    Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
    Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
    Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
    J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperkalemia complicating propranolol treatment of an infantile hemangioma.
    Pavlakovic H; Kietz S; Lauerer P; Zutt M; Lakomek M
    Pediatrics; 2010 Dec; 126(6):e1589-93. PubMed ID: 21115582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late rebound of infantile hemangioma after cessation of oral propranolol.
    Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
    Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
    Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
    Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propranolol safety profile in children.
    El-Shabrawi M; Hassanin F
    Curr Drug Saf; 2011 Sep; 6(4):259-66. PubMed ID: 22129321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemangiomas in childhood].
    Schöni MH; Kernland Lang K
    Praxis (Bern 1994); 2011 May; 100(10):575-82, quiz 583-4. PubMed ID: 21563093
    [No Abstract]   [Full Text] [Related]  

  • 35. A retrospective study of propranolol therapy in 635 infants with infantile hemangioma.
    Luo Y; Zeng Y; Zhou B; Tang J
    Pediatr Dermatol; 2015; 32(1):151-2. PubMed ID: 24602103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemangiomas of the nasal tip treated with propranolol.
    Ben-Amitai D; Halachmi S; Zvulunov A; Raveh E; Kalish E; Lapidoth M
    Dermatology; 2012; 225(4):371-5. PubMed ID: 23428617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergic contact dermatitis caused by topical propranolol therapy for infantile haemangioma.
    Mahmoud I; Kotirkova D; Gospodinova K; Darlenski R; Kazandjieva J
    Contact Dermatitis; 2023 Jul; 89(1):62-63. PubMed ID: 37011641
    [No Abstract]   [Full Text] [Related]  

  • 38. Childhood wheeze while taking propranolol for treatment of infantile hemangiomas.
    Shepherd D; Adams S; Wargon O; Jaffe A
    Pediatr Pulmonol; 2012 Jul; 47(7):713-5. PubMed ID: 22170856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, controlled trial of oral propranolol in infantile hemangioma.
    Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
    N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More on propranolol for hemangiomas of infancy.
    Siegfried EC; Keenan WJ; Al-Jureidini S
    N Engl J Med; 2008 Dec; 359(26):2846; author reply 2846-7. PubMed ID: 19109584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.